Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives

Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological cancers. Despite improvements in medical treatments, the prognosis for EOC remains poor, and there is an urgent need for new therapeutic strategies. Immune checkpoint inhibitors (CPIs) have dramatically improved surviv...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diagnostics (Basel)
Asıl Yazarlar: Borella, Fulvio, Ghisoni, Eleonora, Giannone, Gaia, Cosma, Stefano, Benedetto, Chiara, Valabrega, Giorgio, Katsaros, Dionyssios
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7151145/
https://ncbi.nlm.nih.gov/pubmed/32156035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10030146
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller